Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
A prospective cohort study of vitamin D in optic neuritis recovery.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.
Neurodegeneration and inflammation in MS: The eye teaches us about the storm.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Targeting erythropoietin for chronic neurodegenerative diseases.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
350
351
352
353
354
355
356
357
358
…
next ›
last »